Management Team

Ken Reali, President & Chief Executive Officer
Ken Reali has been our Chief Executive officer and member of our Board since January 4, 2011 and our President since January 2010 Mr. Reali was initially hired by us as our President and Chief Operating Officer in January 2010. He joined us from Smith & Nephew where he spend five years in various general management roles, including most recently as Senior Vice President and General Manager of the Biologics and Clinical Therapies Business. Prior to joining Smith & Nephew, Mr. Reali held senior marketing, sales and product development positions of increasing responsibility at Stryker for seven years. Prior to joining Stryker, Mr. Reali worked as a sales representative and marketing product manager at Biomet for eight years. Mr. Reali received a B.S degree in Business from Valparaiso University.

Mr. Reali has extensive experience and attributes that qualify him to serve on our Board beyond serving as our President and Chief Executive Officer. He has over 22 years of general management, sales, product development, reimbursement and marketing experience with leading medical device and orthopedic companies. His broad experience in management, product development, marketing and international markets have given him valuable insight in assessing overall business strategies and risks and will enable him to expand our business globally.

Joseph Slattery, Executive Vice President & Chief Financial Officer
Joseph Slattery has been our Executive Vice President and Chief Financial Officer since April 2010. Mr. Slattery served as a member of our Board from November 2007 until April 2010 and resigned in connection with his appointment as an officer. From October 1, 2006 through August 3, 2007, Mr. Slattery served as Chief Financial Officer and Senior Vice President of Finance and Information Systems of Digene Corporation, a molecular diagnostics company that was acquired by Qiagen, N.V. in August, 2007. Prior to being appointed Chief Financial Officer, he served as Senior Vice President, Finance and Information Systems, beginning in September 2002. Previously, he served as Vice President, Finance, from July 1999 to September 2002 and as Controller from February 1996 to July 2000. Mr. Slattery served on the board of directors of Micromet, Inc., a publicly-held biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, which was acquired by Amgen in March 2012, and CVRx, Inc. a privately-held company developing implantable technology for the treatment of hypertension and heart disease. Mr. Slattery received a B.S. degree in Accountancy from Bentley University and is a Certified Public Accountant.

Dwayne Montgomery, Vice President of Commercial Operations
B. Dwayne Montgomery has been our Vice President of Sales since March 2010. Mr. Montgomery has nearly 20 years of sales leadership, general management and marketing experience with medical device and orthopedic companies. He joined us from Linvatec Corporation where he was most recently Vice President of Sales. Mr. Montgomery was employed at Linvatec Corporation from 2008 until March 2010. Prior to Linvatec Corporation, Mr. Montgomery was the Vice President & General Manager at Smith & Nephew, Inc. from 2003 until 2008 and a Regional Sales Manager at Guidant Corporation from 1993 to 2003. Mr. Montgomery received a B.S. degree in Chemistry and a minor in Biology from the University of North Alabama and an M.B.A. degree from Belmont University.

Rick Feiler, Vice President of Marketing
Rick Feiler has been Vice President of Marketing since August 2010. Prior to joining TranS1, Mr. Feiler served in sales and sales management roles at Inlet Medical, SurgRx and Weck/CV Evolution. From 2001-2003 he served as Vice President of Market Development and Vice President of Business Development at Teleflex Medical. From 1997-2000, Mr. Feiler served as Vice President of Marketing at Dexterity Surgical, where he was instrumental in development of the Hand-Assisted Laparoscopic Surgery market segment. Mr. Feiler served in marketing roles of increasing responsibility at Weck/Pilling Weck from 1991-1997 and at Valleylab from 1989-1991. Mr. Feiler received a B.A. in Biochemistry and Molecular/Cellular/Developmental Biology from the University of Colorado and an MBA from Northwestern University’s J.L. Kellogg Graduate School of Management.

Stephen Ainsworth, Ph.D., Vice President of Research and Development
Steve Ainsworth has been Vice President of Research and Development since 2010. He has over 15 years of R&D experience with leading medical device companies. He joined TranS1 from Closure Medical Corporation, where he served as Senior Biomedical Scientist. Prior to Closure Medical, Dr. Ainsworth held various engineering positions at Coalescent Surgical, Inc. and Guidant Corporation. Dr. Ainsworth received a B.S. in Mechanical Engineering from Rensselaer Polytechnic Institute and a Ph.D. in Bioengineering from Clemson University.

Mickey Ramchandani, Vice President and General Manager of International
Mickey Ramchandani joined TranS1 June 2008 and has been Vice President and General Manager of International since February 2012. Mr. Ramchandani has over 15 years experience in the life science industry, with experience ranging from research to marketing, business development and corporate strategy. Prior to joining TranS1, Mr. Ramchandani was at Kowa Research Institute, a US affiliate of a Japanese pharmaceutical company, Kowa Company Ltd. At Kowa, Mr. Ramchandani was responsible for all in-licensing, out-licensing and acquisitions. Prior to Kowa, Mr. Ramchandani started a device import and sales company called OBX Medical. Mr. Ramchandani also served at Baxter for 5 years, starting as a Senior Marketing Manager and for the last 3 years as Director, Global New Business. Mr. Ramchandani was also part of the Drug Discovery team at Pfizer from 1990 through 1994. Mr. Ramchandani received a B.S. in Chemistry from Campbell University, a M.S. in Organic Chemistry from East Carolina University and an MBA from UNC-Chapel Hill’s Kenan-Flagler School of Business.